These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 26762752

  • 1. Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.
    Osarogiagbon RU, Lin CC, Smeltzer MP, Jemal A.
    J Thorac Oncol; 2016 Jan; 11(1):e5-16. PubMed ID: 26762752
    [Abstract] [Full Text] [Related]

  • 2. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
    Higgins KA, Chino JP, Ready N, D'Amico TA, Berry MF, Sporn T, Boyd J, Kelsey CR.
    J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
    [Abstract] [Full Text] [Related]

  • 3. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
    Okami J, Higashiyama M, Asamura H, Goya T, Koshiishi Y, Sohara Y, Eguchi K, Mori M, Nakanishi Y, Tsuchiya R, Miyaoka E, Japanese Joint Committee of Lung Cancer Registry.
    J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spine.
    Collaud S, Waddell TK, Yasufuku K, Pierre AF, Darling GE, Cypel M, Rampersaud YR, Lewis SJ, Shepherd FA, Leighl NB, Cho J, Bezjak A, Tsao MS, Keshavjee S, de Perrot M.
    J Thorac Oncol; 2013 Dec; 8(12):1538-44. PubMed ID: 24389435
    [Abstract] [Full Text] [Related]

  • 5. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
    Saji H, Tsuboi M, Yoshida K, Kato Y, Nomura M, Matsubayashi J, Nagao T, Kakihana M, Usuda J, Kajiwara N, Ohira T, Ikeda N.
    J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
    [Abstract] [Full Text] [Related]

  • 6. Node-negative non-small cell lung cancer: pathological staging and survival in 1765 consecutive cases.
    Robinson BM, Kennedy C, McLean J, McCaughan BC.
    J Thorac Oncol; 2011 Oct; 6(10):1691-6. PubMed ID: 21869717
    [Abstract] [Full Text] [Related]

  • 7. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.
    Sakurai H, Asamura H, Goya T, Eguchi K, Nakanishi Y, Sawabata N, Okumura M, Miyaoka E, Fujii Y, Japanese Joint Committee for Lung Cancer Registration.
    J Thorac Oncol; 2010 Oct; 5(10):1594-601. PubMed ID: 20736855
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
    Morgensztern D, Waqar S, Subramanian J, Gao F, Trinkaus K, Govindan R.
    J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
    [Abstract] [Full Text] [Related]

  • 9. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis.
    Mokhles S, Nuyttens JJ, Maat AP, Birim Ö, Aerts JG, Bogers AJ, Takkenberg JJ.
    Ann Surg Oncol; 2015 Jan; 22(1):316-23. PubMed ID: 24962941
    [Abstract] [Full Text] [Related]

  • 10. Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database.
    Osarogiagbon RU, Yu X.
    J Thorac Oncol; 2012 Dec; 7(12):1798-1806. PubMed ID: 23154551
    [Abstract] [Full Text] [Related]

  • 11. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
    Sonobe M, Yamada T, Sato M, Menju T, Aoyama A, Sato T, Chen F, Omasa M, Bando T, Date H.
    Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
    [Abstract] [Full Text] [Related]

  • 12. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase.
    Liu J, Hancock JG, Moreno AC, Wang Z, Boffa DJ, Detterbeck FC, Kim AW.
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):596-601. PubMed ID: 25890936
    [Abstract] [Full Text] [Related]

  • 13. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C, Dong W, Su B, Liu Q, Du J.
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [Abstract] [Full Text] [Related]

  • 14. Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest.
    Zeliadt SB, Sekaran NK, Hu EY, Slatore CC, Au DH, Backhus L, Wu DY, Crawford J, Lyman GH, Dale DC.
    J Thorac Oncol; 2011 Oct; 6(10):1726-32. PubMed ID: 21857253
    [Abstract] [Full Text] [Related]

  • 15. Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage II.
    Toffalorio F, Radice D, Spaggiari L, Sinno V, Barberis M, Spitaleri G, Giovannini M, Delmonte A, Catania C, Noberasco C, Brambilla D, de Braud F, Veronesi G, Solli P, De Pas T.
    J Thorac Oncol; 2012 Jul; 7(7):1124-30. PubMed ID: 22610258
    [Abstract] [Full Text] [Related]

  • 16. Unsuspected residual disease at the resection margin after surgery for lung cancer: fate of patients after long-term follow-up.
    Lequaglie C, Conti B, Brega Massone PP, Giudice G.
    Eur J Cardiothorac Surg; 2003 Feb; 23(2):229-32. PubMed ID: 12559347
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
    Feng W, Li Y, Shen L, Cai XW, Zhu ZF, Chang JH, Xiang JQ, Zhang YW, Chen HQ, Fu XL.
    Oncotarget; 2016 Feb 09; 7(6):7227-40. PubMed ID: 26811495
    [Abstract] [Full Text] [Related]

  • 18. Impact of adjuvant treatment for microscopic residual disease after non-small cell lung cancer surgery.
    Hancock JG, Rosen JE, Antonicelli A, Moreno A, Kim AW, Detterbeck FC, Boffa DJ.
    Ann Thorac Surg; 2015 Feb 09; 99(2):406-13. PubMed ID: 25528723
    [Abstract] [Full Text] [Related]

  • 19. Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.
    Kasprzyk M, Dyszkiewicz W, Piwkowski C, Brudlo M, Galecki B, Gabryel P, Gasiorowski L.
    Neoplasma; 2013 Feb 09; 60(1):62-7. PubMed ID: 23067218
    [Abstract] [Full Text] [Related]

  • 20. Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients.
    Enatsu S, Yoshida J, Yokose T, Nishimura M, Nishiwaki Y, Shirakusa T, Nagai K.
    Ann Thorac Surg; 2006 Jan 09; 81(1):298-304. PubMed ID: 16368385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.